LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
VRSN VeriSign
- 203.950
- +1.220+0.60%
Close Dec 27 16:00 ET
- 206.600
- +2.650+1.30%
Post 20:01 ET
19.60BMarket Cap23.77P/E (TTM)
206.200High201.930Low569.62KVolume204.338Open202.730Pre Close116.02MTurnover0.60%Turnover Ratio25.82P/E (Static)96.10MShares208.03552wk High-10.31P/B19.41BFloat Cap167.04552wk Low--Dividend TTM95.16MShs Float257.030Historical High--Div YieldTTM2.11%Amplitude3.329Historical Low203.684Avg Price1Lot Size
VeriSign Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 3.30%253.4M | 10.39%160.4M | -0.66%257.3M | 2.73%853.8M | -5.86%204.2M | -6.45%245.3M | 0.28%145.3M | 25.06%259M | 2.96%831.1M | 5.14%216.9M |
| Net income from continuing operations | 6.79%201.3M | 7.05%198.8M | 8.62%194.1M | 21.34%817.6M | 47.47%264.7M | 11.21%188.5M | 11.00%185.7M | 13.46%178.7M | -14.14%673.8M | -45.62%179.5M |
| Depreciation and amortization | -16.67%9M | -17.70%9.3M | -15.52%9.8M | -5.97%44.1M | -11.11%10.4M | -5.26%10.8M | -5.04%11.3M | -2.52%11.6M | -2.09%46.9M | -4.88%11.7M |
| Other non cash items | -50.00%500K | -33.33%600K | -9.09%1M | -13.16%3.3M | -90.32%300K | 225.00%1M | 0.00%900K | 83.33%1.1M | -40.63%3.8M | 210.00%3.1M |
| Change In working capital | -16.75%32.3M | 7.14%-58.5M | -23.36%44.3M | -177.38%-43.1M | -582.39%-76.7M | -41.03%38.8M | -28.83%-63M | 152.40%57.8M | 165.61%55.7M | 110.66%15.9M |
| -Change in other current assets | 137.04%1M | -420.69%-15.1M | -315.79%-4.1M | -115.79%-1.5M | -81.67%2.2M | 25.00%-2.7M | 59.72%-2.9M | -77.11%1.9M | 167.86%9.5M | 110.53%12M |
| -Change in other current liabilities | -17.23%26.9M | 16.45%-50.8M | -166.12%-8M | 83.46%-2.2M | --14M | --32.5M | ---60.8M | --12.1M | -1,050.00%-13.3M | ---- |
| -Change in other working capital | -51.11%4.4M | 957.14%7.4M | 28.77%56.4M | -166.22%-39.4M | -305.68%-92.9M | -83.36%9M | 158.33%700K | 48.47%43.8M | 182.30%59.5M | 85.84%-22.9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 3.30%253.4M | 10.39%160.4M | -0.66%257.3M | 2.73%853.8M | -5.86%204.2M | -6.45%245.3M | 0.28%145.3M | 25.06%259M | 2.96%831.1M | 5.14%216.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 128.40%60.5M | 37.26%-249.9M | 21.13%496.4M | -127.38%-97.4M | 154.70%104.1M | -537.72%-213M | -825.50%-398.3M | -21.87%409.8M | 232.13%355.7M | -251.76%-190.3M |
| Net PPE purchase and sale | 80.42%-5.6M | -41.54%-9.2M | 33.33%-3.8M | -67.15%-45.8M | 35.06%-5M | -314.49%-28.6M | -4.84%-6.5M | 13.64%-5.7M | 48.30%-27.4M | 42.96%-7.7M |
| Net investment purchase and sale | 135.85%66.1M | 38.57%-240.7M | 20.39%500.2M | -113.47%-51.6M | 159.75%109.1M | -595.85%-184.4M | -741.24%-391.8M | -21.77%415.5M | 277.20%383.1M | -349.75%-182.6M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 128.40%60.5M | 37.26%-249.9M | 21.13%496.4M | -127.38%-97.4M | 154.70%104.1M | -537.72%-213M | -825.50%-398.3M | -21.87%409.8M | 232.13%355.7M | -251.76%-190.3M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -37.14%-299.1M | -75.10%-390.3M | -17.57%-261.6M | 14.10%-889.8M | -5.70%-226.3M | 20.34%-218.1M | 36.59%-222.9M | -13.29%-222.5M | -44.04%-1.04B | -15.23%-214.1M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | -36.29%-303.1M | -75.10%-390.3M | -17.09%-269.9M | 14.00%-901.4M | -5.37%-225.6M | 19.97%-222.4M | 36.59%-222.9M | -12.66%-230.5M | -45.05%-1.05B | -15.23%-214.1M |
| Proceeds from stock option exercised by employees | -6.98%4M | --0 | 3.75%8.3M | 0.00%12.3M | --0 | 4.88%4.3M | --0 | -2.44%8M | -0.81%12.3M | --0 |
| Net other financing activities | ---- | ---- | ---- | ---700K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -37.14%-299.1M | -75.10%-390.3M | -17.57%-261.6M | 14.10%-889.8M | -5.70%-226.3M | 20.34%-218.1M | 36.59%-222.9M | -13.29%-222.5M | -44.04%-1.04B | -15.23%-214.1M |
| Net cash flow | ||||||||||
| Beginning cash position | -26.26%257.5M | -10.65%737.2M | -35.22%245.5M | 65.65%379M | -71.20%163M | -42.90%349.2M | 8.01%825.1M | 65.65%379M | -44.28%228.8M | 115.58%565.9M |
| Current changes in cash | 107.97%14.8M | -0.82%-479.8M | 10.26%492.1M | -188.34%-133.4M | 143.73%82M | -312.89%-185.8M | -213.71%-475.9M | -16.61%446.3M | 183.38%151M | -458.04%-187.5M |
| Effect of exchange rate changes | 200.00%400K | --100K | -100.00%-400K | 87.50%-100K | -16.67%500K | 42.86%-400K | --0 | -100.00%-200K | -14.29%-800K | 700.00%600K |
| End cash Position | 67.30%272.7M | -26.26%257.5M | -10.65%737.2M | -35.22%245.5M | -35.22%245.5M | -71.20%163M | -42.90%349.2M | 8.01%825.1M | 65.65%379M | 65.65%379M |
| Free cash flow | 14.35%247.8M | 8.93%151.2M | 0.08%253.5M | 0.54%808M | -4.78%199.2M | -15.12%216.7M | 0.07%138.8M | 26.33%253.3M | 6.56%803.7M | 8.51%209.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |